(V610)
|
Deranged progenitor cell mobilization from the bone marrow disturbs endothelial regeneration in Apolipoprotein E – deficient mice
|
|
M. Steinmetz, E. Lucanus, C. Peseke, K. Paul, S. Zimmer, G. Nickenig, N. Werner (Bonn)
|
(V611)
|
A novel bispecific protein/monoclonal antibody molecule (GPVI-Fc/CD133Ab) to capture circulating EPCs facilitates re-endothelialization of vascular lesions
|
|
H.-F. Langer, J. von der Ruhr, K. Daub, T. Schönberger, K. Stellos, A. May, A. Gauss, R. Hafner, H.-J. Buehring, K. Klingel, S. Conrad, M. Schaller, M. van Zaandvort, G. Jung, T. Skutella, M. Gawaz (Tübingen; Maastricht, NL)
|
(V612)
|
Entwicklung bispezifischer ‘single chain’ Antikörper zum Stammzellhoming am atherosklerotischen Gefäßendothel
|
|
I. Ahrens, F. Klingberg, E. Leitner, F. Jia, N. Bassler, C. Bode, C. Hagemeyer, K. Peter (Freiburg im Breisgau; Melbourne, AU)
|
(V613)
|
Resolution of chronic ischemia by regional application of emrbyonic eEPCs or Thymosin ß4 in a preclinical pig model
|
|
R. Hinkel, A. Wuchrer, J. C. Horstkotte, C. Lebherz, A. K. Hatzopoulos, I. Bock-Marquette, M. DiMaio, P. Boekstegers, C. Kupatt (München; Nashville, Dallas, US)
|
(V614)
|
Factors that control Homing of Haematopoetic Stem- and Progenitor Cells (HSPC) into the murine Bone Marrow as well as into the arterial vessel wall in atherosclerosis.
|
|
M. Orban, S. Massberg (München)
|
(V615)
|
Intra-arterial Administration of Bone Marrow Mononuclear Cells in Patients with Critical Limb Ischemia – a randomized, placebo-controlled trial (PROVASA).
|
|
D. Walter, H. Krankenberg, J. Balzer, C. Kalka, I. Baumgartner, M. Schlüter, T. Tonn, S. Dimmeler, E. Lindhoff-Last, A. M. Zeiher (Hamburg, Frankfurt am Main; Bern, CH)
|